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COVID‐19 Impact on Substance Use and Treatment

Overview
The mission of the University of Vermont Center on Rural Addiction
(UVM CORA) is to expand addiction treatment capacity in rural
counties in New Hampshire, Vermont, Maine, northern New York, and
throughout the country by providing consultation, resources, training,
and evidence‐based technical assistance to healthcare providers and
staff. Our New Hampshire baseline needs assessment, conducted in
collaboration with the New Hampshire Citizens Health Inititative at
the University of New Hampshire Institute for Health Policy and
Practice, aimed to identify current and future substance use disorder
(SUD) treatment needs and
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Methods and Sample
From October 2020 to March 2021, we surveyed practitioners and
community stakeholders working across New Hampshire using an
online survey. First, we used mailers, social media, and email listservs
to disseminate a link to an online screening survey. After verifying that
respondents were practitioners or community stakeholders working
in New Hampshire, we emailed a link to the baseline needs
assessment survey.
Survey respondents included 152 practitioners, 81 of whom reported
working in rural counties; and 101 community stakeholders, 74 of
whom reported working in rural counties (Figure 1). The majority of
practitioner respondents were in nursing and counseling roles (Table
1). Community stakeholder respondents reported working in a variety
of settings, including family resource centers/support settings (19%),
recovery centers/recovery community organizations (13%), public
health settings (13%) and community mental health settings (7%).

Figure 1. New Hampshire practitioner (P) and community
stakeholder (CS) respondents in rural (green) and non‐
rural (grey) counties. This map excludes 19 practitioners
and 12 community stakeholders who reported working in
multiple counties.

Table 1. Professional roles of practitioner
respondents

Professional role
Nurse Practitioner
Counselor
Primary Care Physician
Alcohol and Drug Counselor
Nurse
Recovery Coach
Case Manager
Other
Specialist Physician
Nursing/Medical Assistant
Advanced Practice Nurse1
Physician Assistant
Pharmacist
Psychologist
Multiple
Total
1

#

%

27
25
19
19
18
13
10
7
5
3
2
1
1
1
1
152

17.8
16.5
12.5
12.5
11.8
8.6
6.6
4.6
3.3
2.0
1.3
0.7
0.7
0.7
0.7
100

Certified Nurse Specialist, Anesthetist, or Midwife
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COVID-19 Impact on Substance Use
A high proportion of practitioners (77%) and community stakeholders (79%) reported
that substance use had increased since the start of the COVID‐19 pandemic. Two
thirds (68%) of practitioners and over half of community stakeholders (57%) believed
that opioid use had increased. Very few practitioners (6%) and community
stakeholders (6%) believed that access to medications to treat opioid use disorder had
increased since the start of the pandemic. These proportions were similar across rural
and non‐rural respondents.

“There has been an increase in
poly‐substance use.”
– Rural Community Stakeholder
“[Substance use] is more
hidden again.”
– Rural Community Stakeholder

Substance Use Disorder Care during COVID-19
Most practitioners reported that they had implemented telehealth appointments to continue treatment for patients with
SUD during the COVID‐19 pandemic (Figure 2). Some practitioners reported making other changes to their practices, such
as changing their prescribing patterns, conducting appointments outdoors, and expanding their hours for SUD treatment.
Reported changes were generally similar across rural and non‐rural practitioners. However, a greater proportion of rural
practitioners than non‐rural practitioners reported conducting appointments outdoors (rural=28%, non‐rural=13%;) and
utilizing telehealth for group sessions (rural=45%, non‐rural=18%).
When asked which processes were working and not working for them as they provided SUD treatment services during the
COVID‐19 pandemic, almost all practitioners reported that reimbursement for telehealth services was working for them
(Figure 3). In contrast, a majority of practitioners reported that conducting random pill counts was not working for them. A
notable proportion of practitioners reported challenges in other areas of their practice, including patient access to cellular
minutes or data for telehealth visits, and care integration and referrals. There were no significant differences in processses
identifed as working or not working between rural and non‐rural practitioners.

*
*

'Working' for practitioners

Figure 2. Measures that practitioners (n=152) have taken to ensure
continued substance use disorder (SUD) treatment for patients during
the COVID‐19 pandemic. Asterisk (*) denotes significant differences in
responses between rural and non rural practitioners.

'Not working' for practitioners

Figure 3. Distribution of practitioner responses to what has been working or
not working for them in regards to substance use disorder treatment during
the COVID‐19 pandemic.

More Information
Please visit uvmcora.org to find more information about our baseline needs assessments in New Hampshire, Vermont,
Maine, and northern New York, as well as resources and technical assistance on SUD treatment.
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